Foot and Mouth Disease (FMD) Vaccine Antigen Concentrate (VAC)

The USDA APHIS is seeking proposals to purchase, store, and convert Foot‑and‑Mouth Disease (FMD) vaccine antigen concentrate (VAC) and to procure finished vaccine over an 18‑year period. This indefinite‑quantity contract will be awarded on a best‑value basis and may be exercised through multiple one‑year ordering periods, with a conversion and delivery ordering period extending through 2044. The effort includes: • Purchase and long‑term storage of FMD VAC. • Conversion of government‑owned VAC into usable vaccine. • Direct purchase of finished FMD vaccine. • Five (5) one‑year ordering windows (2026‑2031) plus a final conversion/delivery window through 2044. • Minimum order threshold of 1 million doses; maximum per order 200 million doses. • Evaluation factors include price, guaranteed shelf‑life, delivery schedule, and technical compliance. • Open to all responsible sources; not set‑aside for small businesses.